UNVC heading back to where the run began. Down over 92%

New Post Public Reply Private Reply Replies (1) Message Board
911$
463
UNVC heading back to where the run began.

Down over 92% on last years high and already back to 2020 prices... 2019 prices coming next. The trip back to dubs is almost inevitable at this point - and it's entirely Dalton's fault.

Dalton has delivered nothing other than his own personal self-enrichment and a 10 year slew of false statements clamoring to the hopes and dreams of his investors. It would seem that thankfully his hollow tweets and social media posts no longer have the desired effect - 33k buys vs 930k sells today.

How can a company that has racked up almost $30M of losses in the last couple of decades see fit to reward its leadership team with almost $13M in deferred payroll and employee benefits?? With these kind of results most CEO's would have been fired years ago, and the only reason Dalton hasn't been is due to him effectively owning the company and the majority of its shares. That alone should make shareholders pause for thought.

Millions in losses, dismissive revenues, shady share dealings, a complete lack of respect for his shareholder obligations and public reporting - and despite his best attempts to associate himself with a myriad of successful companies, ultimately Univec has no real business.

Failure is allegedly not in his DNA, but I would imagine his high profile son-in-law must be getting nervous by association.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

OnTime's Bold Vision: Transforming Home Healthcare Admin

Updated Category News Views 7

Changing the Game for Home Healthcare Every now and then, an idea rolls in that speaks to a real need, and OnTime's push to soften the burdens of the home healthcare industry might just be one of those. Built from grassroots experience, they're dropping efforts to modernize the back-end monotony so healthcare workers can zero in on, well, healthcare. A Nose-Dive into...

Continue Reading
Image Analysis Group Unveils DYNAMIKA V.7 for Clinical Trials

Updated Category News Views 185

Introduction to DYNAMIKA V.7 by Image Analysis Group Image Analysis Group (IAG) has recently launched DYNAMIKA V.7, an advanced cloud platform tailored for clinical trial imaging. Following stringent audits and certifications, including SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification, this platform stands out in its field....

Continue Reading
Sanofi's Strategic Move to Enhance Adult Vaccination Pipeline

Updated Category News Views 95

Sanofi Strengthens Its Vaccination Portfolio Sanofi SA (NASDAQ: SNY) has made a significant step in the healthcare sector by acquiring Dynavax Technologies Corporation (NASDAQ: DVAX) for approximately $2.2 billion. This acquisition, which involves a cash purchase price of $15.50 per share, signals Sanofi's commitment to enhancing its capabilities in the adult immunization...

Continue Reading
Miral Impact Fund: A New Era for Community and Environment

Updated Category News Views 135

Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...

Continue Reading
Class Action Update for Regeneron Pharmaceuticals Investors

Updated Category News Views 125

Class Action Lawsuit Overview for Regeneron Pharmaceuticals Levi & Korsinsky, LLP has announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) investors should take note of a pending class action lawsuit concerning alleged securities fraud. Understanding the Class Action The lawsuit aims to recover losses for investors adversely affected by claims of fraud that...

Continue Reading